search
date/time
Yorkshire Times
A Voice of the North
frontpagebusinessartscarslifestylefamilytravelsportsscitechnaturefictionwhatson
11:00 AM 22nd March 2021
scitech

Groundbreaking New Technology To Detect Known Variants Of Concern

New technology to rapidly detect new COVID mutations indicating whether positive test samples contain known variants is being trialled by the government in NHS Test and Trace laboratories.

New tech will help identify mutations linked to variants of concern
Rapid turnaround times will help trace contacts of positive cases quicker than before
Suppressing variants of concern key to the government’s roadmap to cautiously ease restrictions

The technology – known as ‘genotype assay testing’ – is set to halve the time it currently takes to identify if a positive COVID-19 sample contains a variant of concern, and could be used in addition to standard testing for COVID-19 to identify cases quickly.

The government’s roadmap sets out that controlling of variants of concerns is an essential part of cautiously easing lockdown restrictions in England. When faced with new variants, swift action has been taken to isolate cases and suppress the spread, including surge testing and enhanced contact tracing. The UK is a global leader in genomic sequencing, which means we are finding more mutations than many other countries.

This new technology will mean that cases of variants of concern are detected faster than before – potentially halving the time it takes to detect a case, which is currently around 4 to 5 days for genomic sequencing. By notifying those affected more quickly, this could allow contacts of positive cases to be traced sooner, breaking the chains of transmission, stop the spread of variants and saving lives.

Surge testing, which involves increased testing and advanced contact tracing, and sequencing has been successfully deployed in a number of targeted locations to help suppress, control and better understand variants of concern. This is in addition to the existing extensive testing capacity NHS Test and Trace has in place.

Health and Social Care Secretary Matt Hancock said:

" Innovation is at the heart of our fight against COVID-19 and has a key part to play in controlling the spread of the virus. We must not stand still if we are to beat COVID-19 and safely ease restrictions in the coming months.

"That is why our goal is to eventually test every COVID positive sample for mutations, that indicate known variants, using this ground breaking new technology. This type of testing will help us rapidly identify variant cases and trace contacts quicker than ever before, helping stop outbreaks in their tracks and ensuring we can continue to follow the roadmap we have set out to get back to normal life."

Health Minister Lord Bethell said:

"The progress made so far developing these new genotype assays is very encouraging and I am confident we will see positive outcomes from piloting this technology.

"Using this test to identify known variant of concern cases has the potential to accelerate our knowledge and understanding of variants of concern and halt their spread across the country."

The government is driving forward progress on expanding regular, rapid testing to help children get back to school and workplaces to stay open, rolling out the vaccine to people all over the UK to ensure those most vulnerable receive the protection it offers as soon as possible, and working to mitigate the risk posed by imported variants, which this new technology will help to support.

Genotype assays would complement existing surveillance work that uses genomic sequencing to look for variants in COVID-positive samples. Genomic sequencing surveillance will continue to detect new variants and mutations. Where new variants or mutations are identified, the technology could be adapted to test for them as well, meaning the technology can be easily deployed to track the variants of most concern.

Appropriate public health measures, including surge testing, will continue to be deployed in areas where there are identified cases of COVID-19 variants of concern and mutations.